Romidepsin in peripheral and cutaneous T‐cell lymphoma: mechanistic implications from clinical and correlative data

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|170|1|96-109

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.170, Iss.1, 2015-07, pp. : 96-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of peripheral T-cell lymphoma: review of the latest clinical data

By Jacobsen Eric D  

Clinical Investigation, Vol. 3, Iss. 7, 2013-07 ,pp. : 665-679

Future Science

Access to resources Recommend Favorite

Acquired generalized lipodystrophy associated with peripheral T cell lymphoma with cutaneous infiltration

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 7, 2015-07 ,pp. : 827-829

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 6, 2015-03 ,pp. : 811-819

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cutaneous manifestations of peripheral T‐cell lymphoma, not otherwise specified: A case series highlighting the diagnostic challenges for this heterogeneous group

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 56, Iss. 3, 2015-08 ,pp. : 197-201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Successful Treatment of Primary Cutaneous Peripheral T-Cell Lymphoma Presenting Acquired Ichthyosis with Oral Bexarotene Monotherapy

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-04 ,pp. : 328-332

Karger

Access to resources Recommend Favorite